← FDA Drug Approvals (Drugs@FDA)

SUGAMMADEX SODIUM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: STERISCIENCE · Approved 2026-07-28

Drug application

FDA Application #

ANDA218814

Application type

Abbreviated New Drug Application (Generic)

Brand name

SUGAMMADEX SODIUM

Generic name

SUGAMMADEX SODIUM

Active ingredients

SUGAMMADEX SODIUM

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

STERISCIENCE

Manufacturer

Par Health USA, LLC

First approval

2026-07-28

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown